Breaking News, Financial News

Sanofi-Aventis 3Q08

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi-Aventis 3Q Revenues: $9.9 billion (-2%) 3Q Earnings: $1.9 billion  (-27%) YTD Revenues: $29.6 billion (-3%) YTD Earnings: $5.3 billion  (-18%) Comments: Pharmaceutical sales in the quarter were up 5% to $8.5 billion, driven by the company’s top 15 products. Lovenox sales were $917.5 million (+9%). Plavix sales were $910.3 million (+6%). Lantus sales were $884.3 million (+29%). Taxotere sales were up 17% to $261.5 million. Aprovel sales were up 15% to $430.6 million. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters